- To go to a passage, click on the appropriate page link and, when the chapter opens, use your browser’s
- “find” command to locate the key word. This index can be quickly navigated by clicking on the letters.
- Accepted Dental Therapeutics, 187
- Advances in Experimental and Clinical Chemotherapy, 94
- Adverse effects, 234-235
- Antineoplastons, 93, 95
- biologically guided chemotherapy, 118, 119
- cellular treatments, 98
- Chinese medicine, 69
- coffee enemas, 51
- defined, 15
- dietary treatments, 42, 47, 60, 63-64
- dimethyl sulfoxide, 99-100
- Gerson treatment, 47
- herbal treatments, 69, 79, 84, 87
- Immuno-Augmentative Therapy, 131-132, 136, 138-140, 143, 233-235
- information on, general 15, 17, 26
- Iscador, 84, 87 laetrile, 103, 107, 201
- Livingston-Wheeler regimen, 110
- macrobiotics, 60, 63-64
- oxygen treatments, 114
- selenium, 118, 119
- vitamin C, 121, 122, 123, 126
- see also Toxicity
- Agua del Sol, 222-223
- AIDS, 136-137, 139-140, 209
- Aihara, Herman, 60 A
- Alliance for Alternative Medicine, 173
- Allopathic medicine, 216
- Alternatives: New Developments in the War Against Breast Cancer, 157
- AMA Drug Evaluations, 187
- American Cancer Society
- dietary regimens, 41, 42, 44, 64, 208
- hydrazine sulfate, 100
- Immuno-Augmentative Therapy, 131, 135
- information dissemination, general, 11, 153, 157, 164-166, 169
- insurance eligibility, 5, 186
- psychosocial support, 30
- Revici, Emanuel 115, 118
- statistics, 11
- Unproven Methods List, 5, 15, 44, 60, 100, 112, 115, 164-166, 168, 191
- American Council on Science and Health, 156-157
- American Medical Association, 5, 12, 215
- Gerson treatment, 4344
- Hoxsey treatment, 81
- Immuno-Augmentative Therapy, 140, 141, 168
- information dissemination, general 11, 153, 157,164, 166-168, 169, 187; see also Journal of the American Medical Association
- insurance reimbursement and, 187, 189, 191
- macrobiotics, 60
- American Quack: Association, 169, 171
- American Society for Clinical Oncology, 140, 141, 164, 168-169, 233
- Animal research, 226-227
- Antineoplastons, 95
- biologically guided chemotherapy, 118
- Essiac, 73
- Immuno-Augmentative Therapy (IAT) 133-135
- laetrile, 103-104
- ozone infusion, 114
- vitamin C, 121
- Annals of the New York Academy of Sciences, 135
- Anthroposophy, 14, 81, 82-84, 85
- Antineoplastons, 14, 91-97, 157, 162, 182, 183, 206-207, 210, 219, 323
- adverse effects, 93, 95
- clinical trials, 93-95
- effectiveness, 93-97
- Food and Drug Administration, 92, 219
- metastasis, 96
- remission, 94-95, 96-97
- Ascorbic acid, see Vitamin C
- Assessment, see Evaluation
- Association of Community Cancer Centers, 166, 191
- Attitudes
- as cancer cause/cure, 29, 31-34
- patients, 3, 24-25, 49, 50, 61, 140, 147, 154-155, 192-193
- Autogenous vaccine, Livingston-Wheeler regimen, 14, 41, 107-111, 183, 211-212
-
- B
- Bacillus Calmette-Guerin, 168
- Bahamas, 15, 131, 136, 137, 139, 143, 145, 146, 147, 149, 162, 179, 234
- Bailar, John, 10, 141
- Barberry, 78
- Basic Macrobiotics, 60
- Beadle, George, 134
- Beard Howard, 104
- Beard, John, 102
- Behavioral approaches, see Psychological and Behavioral approaches
- Benjamin, Harold, 30
- Bergsagel, Daniel, 96
- Best case approach, 23, 25, 97, 142, 231-233
- Beta carotene, 63, 113
- Biological approaches, see Immuno-Augmentative Therapy; Immunological system; Pharmacologic and biologic approaches
- Biologically guided chemotherapy (Revici), 14, 115-120, 169, 173-174, 202, 203, 220-221
- Biological response modifiers, 12
- Blackstein, Martin, 96
- Bladder and bladder cancer, 93, 94-95, 99, 185
- Block, Keith, 13-14, 44
- Blood products, Immuno-Augmentative Therapy, 4, 8, 15, 19, 22, 131-149, 153, 158, 162, 168, 173, 182, 192, 211, 230-231, 234-235
- Blue Cross/Blue Shield, 187-188, 190, 195
- Bone cancer, 93, 96, 122-123, 127
- Boyle v. Revici, 223
- Breast cancer, 11, 33, 36-37, 92, 93, 95, 103-104, 106, 108, 111, 135, 157
- Brenner, Seymour, 120
- Buckthorn, 78
- Burdock, 78
- Burk, Dean, 104
- Burton, Lawrence, 15, 131-149 (passim), 158
- Burzynski, Stanislaw, 14, 91-97, 157, 163, 182, 183, 194, 206-207, 210, 219
- C
- CA-A Cancer Journal for Clinicians, 166
- Cachexia, 92, 100
- Caisse, Rene, 14, 71-72, 73-74
- California Institute of Technology, 133, 134
- Cameron, Ewan, 21, 120-127 (passim)
- Canada, 14, 71, 74-75, 179, 181
- Cancer and Vitamin C, 122
- Cancer: A New Breakthrough, 109
- Cancer as a Turning Point, 33
- Cancer Control Journal, 169
- Cancer Control Society, 113, 169-170
- Cancer Forum, 171
- Cancer Information Service, 25, 153, 161-163
- Nieper, Hans, 112
- Cancer Manual, 166
- The Cancer Prevention Diet, 60, 61, 62, 64
- The Cancer Survivors and How They Did It, 138, 157
- A Cancer Therapy: Results of Fifty Cases, 45, 47, 48
- Cancer? Think Curable: The Gerson Therapy, 48
- Cancer Victors Journal, 170
- Cascara, 78
- Case histories
- Antineoplastons, 96-97
- biologically guided chemotherapy, 117
- dietary treatments, 20-21, 45, 48, 55-58
- Gerson treatment, 45, 48
- herbal treatments, 71, 74, 80-81
- Immuno-Augmentative Therapy, 142-143
- Kelley regimen, 55-58
- laetrile, 104-106
- macrobiotics, 65-66
- Pau D’Arco, 87
- vitamin C, 122
- Cassileth, Barrie, 18, 139, 140-141, 153, 185, 218, 230-231
- Cellular treatment, 97-98
- Center for Alternative Cancer Research, 172
- Centers for Disease Control, 131, 137, 139
- Certification, see Licenses and permits
- Cervical cancer, 96
- Chaparral, 70-71
- Charting the Journey: The Cancer Survivors’ Almanac of Resources, 157
- Chelation therapy, 189, 219
- Chemotherapy, 11-12, 202
- biologically guided (Revici), 14, 115-120, 169, 173-174, 202, 203, 220
- breast cancer, 36
- colon/rectal cancer, 10, 11
- conventional, 8-9
- fraud, 194
- herbal sources, 69
- Children, 18, 200
- Chiropractic treatment, 187
- Chlebowski, Rowan, 101
- The Choice, 172
- City of Carter Lake v. Aetna, 192
- Civilian Health and Medical Program of the Uniformed Services, 186
- Civil suits, see Litigation
- Clement, John, 132, 141, 143
- Clinical Oncology, 166
- Clinical trials, 12, 21-23, 162, 227-230, 234, 235
- adjunctive treatments, 229
- Antineoplastons, 93-95
- biologically guided chemotherapy, 119-120
- eumetabolics, 113
- Gerson treatment, 49
- herbal treatments, 69, 80-81
- hydrazine sulfate, 15, 21, 100-101
- Immuno-Augmentative Therapy (IAT) 22, 142-149
- insurance eligibility and, 177-178
- Iscador, 86
- laetrile, 21-22, 104-105, 106-107
- Livingston-Wheeler regimen, 110
- radiotherapy, 9
- vitamin, C, 21, 122-125, 126
- Coalition for Alternative Medicine, 172-173
- Coalition for Alternatives in Nutrition and Healthcare, 169, 171
- Coffee enemas, 45-46, 47, 51, 49, 52, 55
- Cole, Donald, 222
- Colon cancer, 10, 11, 36, 56, 84, 93, 96, 106, 123,125, 144, 148
- Committee for Freedom of Choice in Medicine, 172, 209
- Commonweal Cancer Help Program, 31
- Comprehensive Crime Control Act, 206
- The Conquest of Cancer, 109
- Consumer protection, 156
- v. “freedom of choice,” 7, 199, 200-203, 209
- litigation, 6
- see also Cancer Information Service; Fraud; Food and Drug Administration
- Contract law, 186, 187-188, 189, 191, 192, 193-195
- Conventional treatment, 8-10, 155
- controversies, 10-11
- evaluation, 226-228
- unconventional treatments and, 178
- see also Diet an nutrition: adjunctive uses
- Costs, 3, 18-19, 177
- clinic charges, factors, 178-185
- dietary treatments, 178, 180,
- information on, 178-179, 181, 182, 185
- biologic and pharmacologic approaches, 179-180, 181, 184
- see also Insurance; Medicare
- Counseling
- psychosocial, 29-31
- spiritual 12
- Court cases, see Litigation
- Crime and criminals, 6, 16, 18, 201, 205-206, 207, 222-223
- fines, 206, 207, 209, 211, 221
- malpractice, 202, 215, 218, 222, 223
- racketeering, 194, 210
- unlicensed practitioners, 16, 26, 199, 215, 217, 222
- see also Fraud
- Criminal Fines Enforcement Act, 206
- Current Procedural Terminology, 194
- Customs controls, see Import controls
-
- D
- Dallis v. Aetna, 192-193
- Data bases, 78, 226
- National Cancer Institute, 153, 161, 163
- Decisionmaking, by patients, 10, 30, 154-155, 157-158
- Defender Magazine, 79
- Department of Health and Human Services, 221
- see also Medicare; specific administrative subunits
- DeVita, Vincent, 100
- Diagnosis
- biologically guided chemotherapy, 117
- costs, 178, 181
- Kelley regimen 53
- Diet and Health, 121
- Diet and nutrition, 12, 13-14, 41-66, 155, 164, 208
- adjunctive uses, 14, 42-43, 44, 101, 110, 111, 122, 229
- adverse effects, 42, 47, 60, 63-64
- American Cancer Society, 41, 42, 44, 64, 208
- carbohydrates, 113
- case histories, 20-21, 45, 48, 55-58
- cost of treatment and, 178, 180, 184
- eumetabolics and, 111, 112-113
- evaluation of, 48-50, 55-58, 64-66, 229
- Gerson Teatment, 13, 22, 41, 43-50, 114, 162-163, 192, 215
- hydrazine sulfate, 101
- Kelley regimen, 13, 20-21, 42, 51, 51-58
- macrobiotics, 12, 14, 41-42, 58-66, 162
- litigation, 192
- Livingston-Wheeler regimen, 110
- quality of life, 43, 49, 50
- sodium, 43, 46, 113
- wheatgrass regimen, 41, 42
- see also specific vitamins
- Diet, Nutrition, and Cancer, 208
- Dimethyl sulfoxide, 14, 99-100, 222
- Disciplinary measures, practitioners, 7, 212, 215, 217-222
- Kelley regimen, 54
- malpractice, 202, 215, 218, 222, 223
- vitamins, 192
- Donsbach, Kurt, 99-100, 114
- Dr. Donsbach Tells You What You Always Wanted to Know About DMSO, 99-100
- Drugs
- see also Chemotherapy; Pharmacologic and biologic approaches
- Drugs Under Experimental and Clinical Research, 94
- Dulbecco, Renato, 134
- E
- Eastern philosophy, 58-59, 60-61
- Economic factors, see Costs; Financial arrangements; Insurance
- Educational attainment, patients, 154
- Educational programs, 166, 216
- Effectiveness, 3, 20, 23-24, 25, 226, 230-233
- Antineoplastons, 93-97
- best case, 23, 25, 51, 97, 142, 231-233
- biologically guided chemotherapy, 116-117, 118
- Federal role, 6, 199,203,205; see also National Cancer Institute, Food and Drug Administration
- Gerson treatment, 47-50
- herbs, 72-73, 77-81, 84-86
- Hoxsey treatment, 77-81
- hydrazine sulfate, 100-102
- imagery and visualization 35-38
- Immuno-Augmentative Therapy (IAT) 132, 148 147 168, 230-231
- information on, 25
- insurance eligibility and, 177-178, 185-186, 189-190 192
- Iscador, 84-86, 87
- Kelley regimen, 56
- laetrile, 103-107, 201-202
- Livingston-Wheeler regimen, 110-111
- macrobiotics, 64
- meditation, 34
- pharmacologic and biologic approaches, 83
- psychological/behavioral approaches, 33
- vaccines, 110-111
- vitamin, C, 120, 121-122, 122-127
- wheatgrass regimen, 41
- see also Clinical trials
- Employee Retirement Income Security Act, 193
- Enemas, 189
- coffee, 45-46, 47, 49, 51, 52, 55
- oxygen, 15, 47, 114
- Essiac, 14, 71-75, 183
- Etoposide, 69
- Eumetabolic treatments, 14, 111-113, 172
- Evaluation, 19-24, 225-235
- Alliance for Alternative Medicine, 173
- American Medical Association, 168, 187
- Antineoplastons, 95-97, 232
- best case, 23, 25, 97, 142, 231-233
- biologically guided chemotherapy, 118-120
- dietary treatments, 48-50, 55-58, 6~66, 229
- Gerson treatment, 48-50, 232
- herbal treatments, 74, 80-81, 86
- history, 4-5
- Hoxsey treatment, 80-81
- hypnosis, 36-37
- Immuno-Augmentative (IAT), 132, 140-147, 168, 230-231, 234-235
- insurance eligibility and, 177-178, 185-186, 189-191
- Kelley regimen, 55-58
- laetrile, 21-22, 103-107, 201-202, 232
- Livingston-Wheeler regimen, 110-111
- macrobiotics, 64-66
- multifaceted treatments, 22
- pharmacological and biological approaches, general, 228-229
- psychobehavioral approaches, 14, 10, 20, 36-37
- radiotherapy, 9
- vitamin, C, 22, 122-127, 232-233
- see also Clinical trials; Effectiveness; Pre-clinical testing; Quality control
- Exceptional Cancer Patients, 31, 36, 231
-
- F
- False Representation Statute, 208
- Federal Government, 203-210, 211-212, 217-218, 221, 234-235
- Essiac, 74-75
- evaluation standards, 5
- evaluation support, 24
- Federal Trade Commission, 7, 162, 164, 167, 207-208
- funding, 5, 24-26
- Hoxsey treatment, 81
- Immuno-Augmentative Therapy, 131
- information dissemination, 24-25, 161-164
- Medicaid, 186, 210
- Medicare, 16, 19, 117, 185, 186-187, 190, 195, 210,221-222, 223
- State governments, relations with, 6, 210, 211-212
- technical assistance, 24
- see also Food end Drug Administration; Laws, specific Federal; National Cancer Institute
- Federal Trade Commission, 7, 162, 164, 167, 207-208
- Federal Trade Commission Act, 207-208
- Federation of State Medical Boards, 218-219
- Fever, 84
- Filary v. General American Life Ins. Co., 193
- Financial arrangement, 177-195
- fraud, billing, 194
- see also Costs; Insurance
- Fines, 206, 207, 209, 211, 221
- Fishbein, Morris, 5, 75
- Fitzgerald, Benedict, 81
- Florida, 131, 140, 161-162
- Food, see Diet and nutrition
- Food and Drug Administration, 6, 7, 19, 22, 203-207, 209, 210, 219, 226, 229-230, 233, 234
- Antineoplastons, 92, 219
- dimethyl sulfoxide, 99
- herbal treatments, 69, 75
- hydrazine sulfate, 100
- Immuno-Augmentative Therapy, 131, 142, 143, 145, 147, 148, 192
- information dissemination, general, 154, 162, 163-164, 166, 167
- insurance reimbursement, 186-192 (passim), 195
- laetrile, 21, 22, 192, 201-202
- Nieper, Hans, 112, 173
- ozone infusion, 114
- Food and Drugs Act of 1906, 6
- Food, Drug, and Cosmetic Act, 5-6, 7, 112, 131, 167, 199-200, 201-202, 203-207, 210, 211, 219
- Foreign countries, 7
- insurance, 8, 49, 187, 188, 189
- see also specific countries and regions
- Foundation for Advancement in Cancer Therapies, 169, 171
- Foundation for Alternative Medicine, 173
- Fraud, 161, 202, 207-209, 210, 221, 222-223
- American Medical Association activities, 5, 167
- information on, 16, 26, 164, 169
- insurance, 19, 186, 189-190, 194, 223
- psychic healers, 13
- Free v. Travelers, 192, 193
- Fritz, Norman, 48
- Funding
- evaluations, 25-26
- research, 5, 24-25
-
- G
- General Accounting Office, 10-11
- Gerber, Michael, 219-220
- Gerson treatment, 13, 22, 41, 43-50, 114, 162-163, 192, 215
- American Medical Association, 43-44
- case histories, 45, 48
- evaluation, 48-50, 232
- metastasis, 49
- State actions, 43, 215
- Gold, Joseph, 100
- Gonzalez, Nicholas, 13, 20, 21, 54-56, 58
- Grossarth-Maticek, Ronald, 36
- Halstead, Bruce, 222-223
- Has Dr. Max Gerson a True Cancer Cure, 7, 48
- Health Care Financing Administration, 186, 187, 190
- Healthcare Rights Advocate, 171
- Health Consciousncss, 171
- Health food stores, 16, 17, 156-157
- Health Freedom News, 170
- Henne v. Mutual of Omaha, 192
- Hepatitis, 136-137, 139
- Herbal treatments, 12, 14, 70-87, 69-87
- adverse effects, 69, 79, 84, 87
- Agua del Sol 222-223
- Anthroposophy, 14, 81, 82-84, 85
- case histories, 71, 74, 80-81
- chaparral 70-71
- clinical trials, 69, 80-81
- costs of, 179, 182
- Essiac, 14, 71-75, 183
- evaluation, 74, 80-81, 86
- Food and Drug Administration 69, 75
- Hoxsey treatment, 14, 73, 75-81, 157, 167, 182, 219
- mistletoe, 13, 14, 81-86, 87
- National Cancer Institute, 69, 74, 78, 80-81
- Pau D’Arco, 14, 86-87
- In re Hofbauer, 202
- Homemaker’s magazine, 72
- Homeopathy, 189, 217
- Hormonal treatment, 9, 110
- Hoxsey: Quacks Who Cure Cancer?, 75, 157, 167
- Hoxsey treatment, 14, 73, 75-81, 157, 167, 181, 219
- American Medical Association, 81
- litigation, 75, 80, 81
- Hydrazine sulfate, 15, 21, 100-102, 163
- Hydrogen peroxide, 114, 209
- Hyperthermia, 168
- financial costs of, 180, 185
- Hypnosis, 33, 36-37
-
- I
- Imagery and visualization, 13, 33, 35-36
- Immuno-Augmentative Therapy (IAT), 4, 8, 15, 19, 22, 131-149, 153, 158, 162, 168, 173, 182, 183, 192, 211, 230-231, 234-235
- adverse effects, 131-132, 136, 138-140, 143, 233-235
- American Cancer Society, 131, 135
- American Medical Association, 140, 141,
- 168 case histories, 142-143
- clinical trials, 22, 142-149
- evaluation, 132, 140-147, 168, 230-231, 234-235
- Food and Drug Administration, 131, 142, 143, 145, 147, 148, 192
- metastasis, 143, 148 National Cancer Institute, 131, 139, 140, 141, 142, 145, 148-149, 234
- patents, 137-140
- preclinical testing, 133-136, 137, 139
- quality of life, 144, 149
- remission, 134, 135, 140
- State actions, 131, 136, 140, 211
- Imperial Cancer Research Fund, 119
- Import controls, 163, 209
- Immuno-Augmentative Therapy, 131
- Nieper, Hans, 112, 173
- Indian rhubarb, 73
- Infection
- Gerson treatment effects, 47
- Immuno-Augmentative Therapy, 136-137, 139-140, 234-235
- Livingston-Wheeler regimen, 14, 41, 107-111, 183, 211-212
- Information and information dissemination 4, 15-16, 17, 19, 24-26
- adverse effects, general, 15, 17, 26
- American Cancer Society, general 11, 153, 157, 164-166, 169
- American Medical Association, general 157, 164, 166-168, 169, 187; see also Journal of thc American Medical Association
- bibliographies, 168
- biologically guided chemotherapy, 116
- cost of treatment, 178-179, 181, 182, 185
- Federal, 24-25, 161-164; see also Cancer Information Service
- Food and Drug Administration, general 154, 162, 163-164, 166, 167
- on fraud, 16, 26, 164, 169
- macrobiotics, 62
- National Cancer Institute, 153, 161-163; see also Cancer Information Service
- Nieper, Hans, 112
- patient sources, 17, 19, 153, 155-157, 178, 182, 185
- private sector, 164-174
- see also Data bases; Mass media; Telephone services;
- Inpatient treatment, costs, 178-181
- Insurance, 18-19, 177-178, 185-195, 213, 215
- American Cancer Society, eligibility and, 5, 186
- American Medical Association, eligibility and 187, 189, 191
- Blue Cross/Blue Shield, 187-188, 190, 195
- commercial 189-190, 191-192
- Food and Drug Administration, 186-192 (passim), 195
- foreign countries, 8, 49, 187, 188, 189
- fraud 19, 186, 189-190, 194, 223
- litigation, 186, 191-194, 195
- Medicaid 186, 210
- Medicare, 16, 19, 117, 185, 186-187, 190, 195, 210, 221-222, 223
- National Cancer Institute, 186, 191
- quality of life, eligibility and, 177, 185-186, 192
- State actions, 188-189, 191, 192, 193
- Integral Cancer Therapy, 138, 157
- Interleukin-2, 12
- International Association of Cancer Victors and Friends, 169, 170
- International Classification of Diseases, 194
- International perspectives, 7-8, 114, 116, 169, 170
- Immuno-Augmentative Therapy, 131, 136, 137
- see also Foreign countries; specific countries an. regions
- International Union Against Cancer, 116
- Intravenous administration
- Antineoplastons, 14
- biologically guided chemotherapy, 118
- Immuno-Augmentative Therapy, 131, 134
- oxygen, 15, 47, 114
- Iscador, 12, 14, 81-82, 83-86, 86
- Ivy, Andrew, 207, 209
- J
- John Birch Society, 102 Johnson, Alva, 111
- Joint Commission on Accreditation of Health Care Organizations, 187
- Journal of the American Medical Association, 5, 11, 44, 75, 77, 115, 119-120, 167, 168
- Journal of the American Quack Association, 171
- K
- Kampen, Frederick van, 116
- Kelley regimen, 13, 20-21, 42, 51-58
- case histories, 55-58
- Krebs, Ernst Jr., 102
- Krebs, Ernst Sr., 102
- Kunst, Leonard, 116
- Kurume University, 95
- Kushi, Michio, 58-66 (passim)<
- L
- Labeling, 112, 173, 208
- Ladas, Harold, 116
- Laetrile, 6, 14,18,21-22,47,99,102-107, 155, 162,192, 201-202, 212
- adverse effects, 103, 107, 201
- case histories, 104-106
- clinical trials, 21-22, 104-105, 106-107
- evaluation, 21-22, 103-107, 201-202, 232
- Food and Drug Administration, 21, 22, 192, 201-202
- National Cancer Institute, 21-22, 103, 105-107, 232
- preclinical testing, 103-104
- remission, 104, 105
- State actions, 102, 201, 202
- LAK cells, 12
- Lancet, 98
- Langer, William, 81
- Laws, specific Federal, 199-212
- Comprehensive Crime Control Act, 206
- conspiracy, 209
- Constitutional, 171, 193, 199-200
- Criminal Fines Enforcement Act, 206
- Employee Retirement Income Security Act, 193
- False Representation Statute, 208
- Federal Trade Commission Act, 207-208
- Food and Drugs Act of 1906, 6
- Food, Drug, and Cosmetic Act, 5-6, 7, 112, 131, 167, 199-200, 201-202, 203-207, 210, 211, 219
- Mail Fraud Statute, 209
- Racketeer Influenced and Corrupt Organizations Act,
- 194, 210 Social Security Act, 186-187, 221
- v. State law, 6
- see also Regulations
- Leap of Faith, 155
- Lechner, Peter, 49
- Legal issues, 3, 5-7, 12, 16, 26, 171, 199-212, 215-223, 226
- advocacy, 155, 161, 165, 169-174, 199
- contracts, insurance, 186, 187-188, 189, 191, 192, 193-195
- fines, 206, 207, 209, 211, 221
- “freedom of choice”, 7, 199, 200-203, 209
- malpractice, 202, 215, 218, 222, 223
- parents, 18
- privacy, 6, 7, 200, 201
- State v. Federal law, 6
- see also Consumer protection; Crimes and criminals; Fraud; Laws, specific Federal; Licenses and permits; Litigation
- Leukemia, 18, 69, 70, 73, 74, 78, 84, 95, 134-135, 202, 226, 227
- LeShan’s Psychotherapy, 13, 33-34
- Licenses and permits, 6, 16,211-212, 215, 216-217,221, 222
- insurance coverage and, 187-188, 189
- unlicensed practitioners, 16, 26, 187, 215, 217, 222
- see also Disciplinary measures, practitioners
- Licorice, 78
- Lichello, Robert, 48
- Litigation, 6, 12, 16, 164, 173-174, 200, 206-207, 208, 209, 210, 211, 216-217, 222-223
- biologically guided chemotherapy, 115
- dietary treatments, 192
- “freedom of choice”, 7, 199, 200-203, 209
- Hoxsey treatment, 75, 80, 81
- insurance coverage, 186, 191-194, 195
- privacy, 6, 7, 200, 201
- see also specific case names
- Liver and liver cancer, 56, 79
- Gerson treatment, 46, 47
- hepatitis, 136-137, 139
- Pau D’Arco, 87
- vitamin C, 123
- Livingston, Virginia, 14, 41, 107-111, 183, 211-212
- Livingston-Wheeler regimen, 14,41, 107-111, 183, 211-212
- Lou Harris Associates, 154, 155, 157, 163
- Lung cancer, 36, 70, 86, 87, 96, 99, 101-102, 106, 119, 123, 143-144
-
- M
- MacLeans (magazine), 93
- Macrobiotics, 12, 14, 4142, 58-66, 162
- adverse effects, 60, 63-64
- American Medical Association, 60
- Mail, see Postal service
- Mail Fraud Statute, 209
- Maisin, Joseph, 116-117
- Malpractice, 202, 215, 218, 222, 223
- see also Disciplinary measures, practitioners
- Mass media, 5, 29, 157, 158
- Antineoplastons, 95,
- Gerson treatment, 44, 48
- Immuno-Augmentative Therapy, 131, 135, 138
- Kelley regimen, 52
- television, 17, 95, 131, 138, 155, 157, 158
- vitamin C, 120
- Mayo Clinic, 21, 106, 122, 123-127, 232-233
- McKee, Dwight, 116
- McLaughlin v. Connecticut General, 192, 193
- McNaughton, Andrew, 102
- Meares, Ainslie, 34
- Medical College of Georgia, 95
- Medical College of Virginia, 100
- Medical Necessity Program (Blue Cross/Blue Shield), 188
- Medicaid, 186, 210
- Medicare, 16, 19, 117, 185, 186-187, 190, 195, 210, 221-222, 223
- Medicine Man, 157, 167
- Meditation, 34
- Medizone International 114
- Melanoma, 49, 56, 71, 106, 185
- Merck Manual of Diagnosis and Therapy, 51
- Metastasis, 155
- Antineoplastons, 96
- biologically guided chemotherapy, 116, 119
- Gerson treatment, 49, 50
- Immuno-Augmentative Therapy, 143, 148
- Iscador, 84, 86, 87
- psychotherapy, 33, 36-37
- vitamin C, 120, 122-123
- Methodological issues clinical trials, 16, 21-22, 49, 80, 81, 125-127,137-138, 143-148, 204-205
- evaluation, general, 4-5, 25, 225-235
- Immuno-Augmentative Therapy, 137-138, 143-148, 230-231
- OTA study, 3-4, 15-16
- pharmacologic/biologic, 20
- vitamin C evaluation, 22, 125-127
- see also Statistical analysis
- MetPath, 138
- Mexico, 11, 13, 15, 41, 43-50, 75,76, 77, 98, 99, 103, 114, 131, 147, 170, 179, 180, 181
- Miller, Mildred, 99
- Minerals and mined supplements
- eumetabolics, 113
- Livingston-Wheeler regimen, 110
- macrobiotics and, 63
- Mistletoe, 13, 14, 81-86, 87
- Mitchell, Herschel, 133, 134
- Mohs, Frederic, 77-78
- Molinari, Guy, 131, 136, 137, 142
- Morgenstern, Hal 36
- Mortality rates, 10
- Mushrooms, 70
- N
- National Academy of Sciences, 208
- National Association of Consumer Agency Administrators, 163
- National Cancer Institute, 5, 11, 25, 208, 227, 233, 234
- Antineoplastons, 92
- biologically guided chemotherapy, 118
- database, 153, 161, 163
- dimethyl sulfoxide, 99
- herbal treatments, 69, 74, 78, 80-81
- Immuno-Augmentative Therapy, 131, 139, 140, 141, 142, 145, 148-149, 234
- information dissemination, general, 153, 161-163; see also Cancer Information Service
- insurance eligibility, 186, 191
- laetrile, 21-22, 103, 105-107, 232
- Medicare, 187
- National Center for Institutions and Alternatives, 223
- National Coalition for Cancer Survivorship, 30
- National Council Against Health Fraud, 164, 169
- National Council on Nutritional Information, 164
- National Formulary, 187
- National Health Care Anti-Fraud Association, 194
- National Health Federation, 100, 102, 169, 170-171
- National Institutes of Health, 161
- see also National Cancer Institute
- National Research Council, 121
- Nelson, Mildred 77, 79
- New England Journal of Medicine, 10, 107
- New York (magazine), 131
- New York Academy of Medicine, 135
- New York Academy of Sciences, 134, 135
- Nieper, Hans, 14, 104, 111-113, 169, 173
- Nordihydroguaiaretic acid, 70-71
- Nutrition, see Diet and nutrition; Macrobiotics; specific vitamins
O
- Ohsawa, George, 59-60
- One Answer to Cancer, 52, 54
- One Man Alone: An Investigation of Nutrition, Cancer, and William Donald Kelley, 20, 55
- Outcomes research, 20, 36-37
- Oxygen treatments, 14-15, 46, 47, 113-114, 188, 209
- P
- Packaging, 200, 208
- labeling, 112, 173, 208
- Pain and pain control, 228
- Chinese medicine, 69
- Gerson treatment, 49, 50
- hypnosis, 36-37
- vitamin C, 121, 122-123, 127
- Pan American Health Organization, 131, 136, 137
- Pancreatic cancer, 123
- Patents
- biologically guided chemotherapy, 118
- Immuno-Augmentative Therapy, 137-140
- Patients
- associations, 169, 170, 173-174
- attitudes, 3, 24-25, 29-31, 49, 50, 140, 147, 154-155, 192-193
- characteristics, 3, 18, 24-25, 29, 153-154
- decision making, 10, 30, 154-155, 157-158
- educational attainment, 154
- information sources, 17, 19, 153, 155-157, 178
- legal status, 6, 7, 200, 201
- see also Financial arrangements; Insurance; Pain and pain control; Quality of life
- Pau D’Arco, 14, 86-87
- Pauling, Linus, 14, 21, 120-127 (passim)
- Penthouse, 131
- People Against Cancer, 172
- Peritoneal mesothelioma, 141, 143, 146, 149
- Personality factors, see Attitudes
- Pharmacologic and biologic approaches, 14-15, 91-127
- Antineoplastons, 14, 91-97, 157, 162, 182, 183, 194, 206-207, 210, 219, 323
- biologically guided chemotherapy (Revici), 14, 115-120, 169, 173-174, 202, 203, 220-221
- conventional, 9-10
- costs, 179-180, 181, 184
- dimethyl sulfoxide, 14, 99-100, 222
- evaluation of, general, 5, 228-229
- FDA approval, 19
- hydrazine sulfate, 15, 21, 100-102, 163
- Immuno-Augmentative Therapy, 4, 8, 15, 19, 22, 131-149, 153, 162, 168, 173, 182, 183, 192, 211, 230-231, 234-235
- laetrile, 6, 14, 18, 21-22, 47, 99, 102-107, 155, 162, 192, 201-202, 212
- Livingston-Wheeler regimen, 14,41, 107-111, 183, 211-212
- Medicare coverage, 186-187
- Nieper, Hans, 14, 104, 111-115, 169, 173
- Revici, Emanual, 14, 115-120, 169, 173-174, 202, 203, 220-221
- see also Chemotherapy; Immunological system; Food and Drug Administration: specific vitamins
- Pharmacopeial Dispensing Information, 186
- pH conditions and measurements, 117, 119
- Physicians
- legal status, 6, 7, 187
- Philippines, 13
- Photodynamic therapy, 9
- Podophyllotoxin, 69
- Pokeroot, 78, 79
- Postal Service, 7, 167, 207, 208-209
- Hoxsey treatment, 75
- hydrogen peroxide infusions, 114
- Immuno-Augmentative Therapy, 131
- Practitioners, general, 16, 199, 215-223
- disciplinary measures, practitioners, 7, 54, 192, 212, 215, 217-222; see also Malpractice
- unlicensed, 16, 26, 187, 215, 217 s
- see also Licenses and permits; Malpractice; specific practitioners
- Preclinical testing, 227-228, 234
- Antineoplastons, 95 biologically guided chemotherapy, 118
- Essiac, 73, 74-75
- Immuno-Augmentative Therapy, 133-136, 137, 139
- laetrile, 103-104
- ozone infusion, 114
- vitamin C, 121
- see also Animal research
- Prickly ash, 78
- Privacy, 6, 7, 200, 201
- Private sector
- advocacy, 169-174
- health food stores, 16, 17, 156-157
- information dissemination, general, 164-174
- insurance, 189-190, 191-195
- Privitera, James, 201, 211
- Project Cure, 171-172
- Prostate cancer, 57, 93, 96, 143
- Psychic surgery, 13
- Psychological and behavioral approaches, 13, 14, 29-37
- American Cancer Society, 30
- costs of, 180, 184
- evaluation, 14, 10, 20, 36-37, 229
- hypnosis, 33, 36-37
- imagery and visualization, 13, 33, 35-36
- LeShan’s psychotherapy, 33-34
- macrobiotics and, 58-59, 60-61
- meditation, 34 psychology, 31-33
- psychosocial support, 13, 29-31, 36
- see also Attitudes; Spiritual approaches
- Public Health Service, 81
-
- Q
- Quackery, see Fraud Quackery Action Council, 164
- Quality of life, 10, 30, 226, 228
- dietary approaches, 43, 49, 50
- Immuno-Augmentative Therapy, 144, 149
- insurance eligibility and, 177, 185-186, 192
- vitamin C, 121, 122
- see also Pain and pain control
- R
- Racketeer Influenced and Corrupt Organizations Act, 194, 210
- Radiation, cancer etiology, 113
- Radiotherapy, 8, 9, 11, 79, 96
- R.A. v. Prudential, 192, 193
- Recalled by Life, 60
- Rectal cancer, 11, 84, 106, 123, 125, 143,148
- Red clover, 78
- Regulations, 6-7, 199-212
- see also Food and Drug Administration; Federal Trade
- Commission; Standards
- Religion, see Spiritual approaches
- Remission, 228
- Antineoplastons, 94-95, 96-97
- biologically guided chemotherapy, 116-117, 118, 119, 120
- clinical trials, 23
- Immuno-Augmentative Therapy, 134, 135, 140
- information on, 16, 26
- laetrile, 104, 105
- vitamin C, 121, 122
- Research
- Center for Alternative Cancer Research, 172
- experimental treatments within conventional channels, 12
- Federal role, 5, 24-25
- historical perspective, 10
- outcomes, 20
- patient characteristics, 24-25
- see also Animal research; Clinical trials; Evaluation; Preclinical testing
- Research in Physiopathology as a Basis of Guided Chemotherapy with Special Application to Cancer, 115
- Resperin Corp, 73, 74, 75
- Revici, Emanual, 14, 115-120, 169, 173-174, 202, 203, 220-221
- American Cancer Society, 115, 118
- Revolution in Technology, Medicine and Society, 112
- Rhubarb, 73
- Risner v. Blue Cross/Blue Shield of Michigan, 193
- Roe v. Wade, 201
- Rohe, Fred, 52-53
- Rosy periwinkle, 69
- Rotmann, Douglas, 121
- S
- Safety, 3, 226, 233-234
- Federal role, 6, 7, 199, 203, 205; see also Food and Drug Administration
- Immuno-Augmentative Therapy, 138-140, 143, 145, 147, 149, 233-235
- insurance eligibility and, 177-178, 185
- see also Adverse effects; Toxicity
- Sarcomas, 78, 84
- Schneider v. Revici, 202, 203, 223
- Science, 114, 134
- Selenium, 116, 118-119
- Shumake v. Travelers, 192
- Side effects, see Adverse effects
- Siegel, Bernie, 31, 36
- Simonton-Atchley, Stephanie M., 13, 35-36
- Simonton, O. Carl 13, 35-36
- 60 Minutes, 131, 138
- Slippery elm, 73
- Sloan-Kettering Cancer Center, 73-74, 100, 104
- Smith, Elaine 10
- Social Security Act, 186-187, 221
- Social support, 13, 29-31, 36
- Sodium, dietary, 43, 46, 113
- Sorrel, 73
- Speckhart, Vincent, 111
- Spiegel, David, 36-37
- Spiritual approaches, 12-13, 53-54, 216
- Anthroposophy, 14, 81, 82-84, 85
- Eastern, 58-59, 60-61
- meditation, 34
- Standards, 15
- clinical trials, 16, 49, 80, 81, 106, 147-149, 204-205, 232, 235
- eligibility, insurance, 185-195
- evidence, 5, 193
- pharmaceuticals, 112, 199
- practitioner, 16; see Licenses and permits
- safety, 7, 15
- Stanford University, 21
- State-level action, 199, 201, 202, 210-212, 215, 217, 218-221, 222-223
- criminal practices, 26
- Federal Government, relations with, 6, 210, 211-212
- Gerson treatment, 43, 215
- Kelley regimen, 54
- Immuno-Augmentative Therapy, 131, 136, 140, 211
- lnsurance coverage, 188-189, 191, 192, 193
- laetrile, 102, 201, 202
- see also Disciplinary measures, practitioners; Licenses
- and permits; Litigation
- Statistical analysis, 21
- hydrazine sulfite, 101
- macrobiotics, 64-05
- methodological issues, 125, 126, 141, 148
- mortality and survival, 10-11, 123, 124, 140-141, 149, 230-231
- Steiner, Rudolph, 12, 82-83
- Stillingia, 79
- Stock, Chester, 104
- Stomach cancer, 70, 123, 185
- Strelkauskas, Anthony, 111
- Sugiura, Kanematsu, 104
- Support groups, 30
- Surgery, 8, 9, 11
- breast cancer, 11
- evaluation of, 5
- psychic, 13
- Switzerland, 81
- T
- Technical assistance 24
- Technology Evaluation and Coverage Program, 188, 189
- Telephone services, 30, 153, 158
- American Cancer Society, 166
- American Medical Association, 168
- Cancer Control Society, 170
- Cancer Information Service, 25, 112, 153, 161-163
- Terminology
- definitional issues, 11-15
- unconventional, alternatives, 4
- Third Opinion, 7, 178, 181
- Third-party payer, see Insurance; Medicare
- Thomas, Elmer, 81
- Toxicity
- Antineoplastons, 93
- dimethyl sulfoxide, 99-100
- herbal treatments, 69, 87
- Immuno-Augmentative Therapy, 139, 140, 234-235
- laetrile, 103, 107
- Livingston-Wheeler regimen, 110
- selenium, 118, 119
- vitamin C, 122
- Travel expenses, 178
U
- University of British Columbia, 80
- University of California, 21
- University of Pennsylvania, 153
- Unproven Methods List (ACS), 5, 15, 44, 60, 100, 112, 115, 164-166, 168, 191
- Urine and urology
- biologically guided chemotherapy, 117, 119
- vitamin C, 122, 123, 126
- U.S. Homeopathic Pharmacopoeia, 187
- U.S. Pharmacopoeia, 187
- U.S. v. Durovic, 209
- U.S. v. Richardson, 209
- U.S. v. Rutherford, 201, 206
- Uterine cancer, 123, 185, 219
- V
- Vaccines, 14
- Bacillus Calmette-Guerin, 168
- Lincoln bacteriophage, 47
- Livingston-Wheeler regimen, 14, 41, 107-111, 183, 211-212
- Visualization and imagery, see Imagery and visualization
- Vitamin A, 43, 44, 63, 104, 110
- Vitamin B12, 44, 63, 64, 110, 187
- Vitamin C, 14, 21, 22, 43, 63, 99, 100, 120-127, 162, 232-233
- adverse effects, 121, 122, 123, 126
- clinical trials, 21, 122-125, 126
- evaluation, 21, 22, 122-127, 232-23
- metastasis, 120, 122-123 quality of life, 121, 122
- remission, 121, 122
- Vitamin D, 64
- Vitamins, 43, 44, 46, 52, 55, 155
- litigation, 192
- macrobiotics and, 63
W
- Walde, David, 95-96
- Warburg, Otto, 114
- War on Cancer, 10
- Washington Post, 100
- Washington State, 136-137
- Wehmeyer v. Prudential, 193
- Weleda, 81
- Wellness Community, 30-31
- West Germany, 8, 14, 15, 81, 111-113, 131, 147
- Wheatgrass regimen, 41, 42
- Wigmore, Ann, 41
- Wilk, Chester, 5
- Women
- psychosocial therapy, 31, 33, 36
- see also Breast cancer
- Y
- Yeast, 83
- You Don’t Have to Die, 75, 75-76
- Z
- Zen Macrobiotics, 59
- Zuckerberg v. Blue Cross and Blue Shield, 192
-
OTA Report Contents
This page was posted on August 3, 1998.
